TrialPloS one2016

Reduced Expression of Galectin-9 Contributes to a Poor Outcome in Colon Cancer by Inhibiting NK Cell Chemotaxis Partially through the Rho/ROCK1 Signaling Pathway.

Yang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.